Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
Where
Jiangxi, Ningbo, Shanghai, Zunyi
Age
18 years to 85 years
People
10,000
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07243873
No phaseTaking people
Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC
Where
Zhengzhou
Age
18 years and over
People
40
Run by
Henan Cancer Hospital
See details and how to joinNCT07244016
Phase 2Not yet taking people in China
Sac-TMT Plus Bevacizumab as Second-Line Treatment for Advanced Non-Squamous Non-Small Cell Lung Cancer
Where
Tianjin
Age
18 years and over
People
31
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07244926
Phase 2Taking people
A Study of Ivonescimab in First-Line ES-SCLC
Where
Beijing, Shanghai, Xi’an
Age
18 years to 75 years
People
180
Run by
Akeso
See details and how to joinNCT07245446
Phase 2Taking people
High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
Where
Shanghai
Age
18 years and over
People
60
Run by
Jialei Wang
See details and how to joinNCT06652048
Phase 3Not yet taking people in China
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC
Where
Beijing
Age
18 years and over
People
472
Run by
Jemincare
See details and how to joinNCT07242274
No phaseNot yet taking people in China
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
Where
Suzhou
Age
18 years to 80 years
People
200
Run by
Zhao Jun
See details and how to joinNCT07242482
Phase 2Taking people
To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
Where
Tianjin
Age
18 years and over
People
64
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06352008
Phase 2Taking people
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
Where
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Ganzhou, Guangzhou, Harbin, Jiangmen, Jinan, Leshan, Nanchang, Nanjing, Nanning, Shanghai, Shenzhen, Tianjin, Ürümqi, Wenzhou, Wuhan, Xi’an, Zhengzhou, Zunyi
Age
18 years to 75 years
People
270
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06496490
Phase 2Taking people
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Where
Shantou
Age
18 years to 80 years
People
48
Run by
Chuangzhen Chen
See details and how to joinNCT07071103
No phaseTaking people
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
Where
Tianjin
Age
18 years and over
People
120
Run by
Kong Fanming
See details and how to joinNCT07239661
Phase 3Taking people
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
Where
Guangzhou
Age
18 years to 75 years
People
524
Run by
Sun Yat-sen University
See details and how to joinNCT04980716
Phase 3Taking people
Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Jinan
Age
18 years to 75 years
People
460
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07170995
Phase 2Taking people
Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Where
Guangzhou
Age
18 years to 75 years
People
200
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07175220
Phase 2Taking people
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases
Where
Guangzhou
Age
18 years and over
People
130
Run by
Sun Yat-sen University
See details and how to joinNCT06542159
Phase 2Taking people
Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis
Where
Guangzhou
Age
18 years to 75 years
People
168
Run by
Sun Yat-sen University
See details and how to joinNCT06582940
Phase 1/2Taking people
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
Where
Chongqing, Hunan, Jinan
Age
18 years to 75 years
People
105
Run by
Shanghai Henlius Biotech
See details and how to joinNCT06848699
Phase 3Taking people
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Where
Guangzhou
Age
18 years to 75 years
People
440
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07178795
Phase 1/2Taking people
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
300
Run by
Minghui Pharmaceutical (Hangzhou) Ltd
See details and how to joinNCT07229599
Phase 1/2Taking people
A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation
Where
Beijing, Guangzhou, Zhengzhou
Age
18 years to 75 years
People
153
Run by
Henan Genuine Biotech Co., Ltd.
See details and how to joinNCT07231068
No phaseTaking people
Intraoperative Paravertebral Block and Postoperative Complications
Where
Wuhan
Age
18 years to 80 years
People
500
Run by
Tongji Hospital
See details and how to joinNCT07211529
Phase 1/2Not yet taking people in China
Penfluridol for Relapsed/Refractory Small Cell Cancers
Where
Wuhan
Age
18 years to 75 years
People
33
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07206563
No phaseTaking people
Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma
Where
Hangzhou
Age
18 years to 85 years
People
39
Run by
First People's Hospital of Hangzhou
See details and how to joinNCT07207278
Phase 1Taking people
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
Where
Hefei
Age
18 years and over
People
108
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07179692
Phase 2Not yet taking people in China
The IVO-LUNG Study
Where
Guangzhou
Age
18 years to 75 years
People
63
Run by
Sun Yat-sen University
See details and how to joinNCT07204548